ID: ALA2381478

Max Phase: Preclinical

Molecular Formula: C18H18N4O

Molecular Weight: 306.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)c1ccc(-n2cc(C(=O)c3cccc(N)c3)nn2)cc1

Standard InChI:  InChI=1S/C18H18N4O/c1-12(2)13-6-8-16(9-7-13)22-11-17(20-21-22)18(23)14-4-3-5-15(19)10-14/h3-12H,19H2,1-2H3

Standard InChI Key:  REMRQYMGZUCAGE-UHFFFAOYSA-N

Associated Targets(Human)

Estrogen-related receptor alpha 573 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 306.37Molecular Weight (Monoisotopic): 306.1481AlogP: 3.20#Rotatable Bonds: 4
Polar Surface Area: 73.80Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.00CX LogP: 3.94CX LogD: 3.94
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.59Np Likeness Score: -1.58

References

1. Xu S, Zhuang X, Pan X, Zhang Z, Duan L, Liu Y, Zhang L, Ren X, Ding K, Ding K..  (2013)  1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor α.,  56  (11): [PMID:23656512] [10.1021/jm4003928]

Source